Antipodes Partners’s Danaher DHR Stock Holding History

Antipodes Partners’s Portfolio DHR Stock Details DHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-137	Closed	-$27.2K	–	134
2025 Q3	$27.2K	Buy	+137	New	+$27.3K	﹤0.01%	108

Other funds holding DHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Antipodes Partners's DHR Position: Q4 2025 in Review

Antipodes Partners sold out of Danaher (DHR) in Q4 2025, closing a stake of 137 shares — an estimated $27.2K sold.

Antipodes Partners first reported a position in DHR in Q3 2025 and held it in 1 quarter. The position peaked at $27.2K in Q3 2025. 2,305 funds tracked by Wall St. Rank hold DHR as of Q4 2025.

Antipodes Partners reported no remaining Danaher position as of Q4 2025 after selling out during the quarter.
Antipodes Partners sold 137 Danaher shares in Q4 2025, an estimated $27.2K.
Antipodes Partners first reported a position in Danaher in Q3 2025 and held it in 1 quarter.
Antipodes Partners's Danaher position peaked at $27.2K in Q3 2025.
2,305 funds tracked by Wall St. Rank held Danaher as of Q4 2025.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.